Abstract
Quantitative proteome analysis of Alzheimer's disease (AD) brains was performed using 2-D gels to identify disease specific changes in protein expression. The task of characterizing the proteome and its components is now practically achievable because of the development and integration of four important tools: protein, EST, and complete genome sequence databases, mass spectrometry, matching software for protein sequences and protein separation technology. Mass spectrometry (MS) instrumentation has undergone a tremendous change over the past decade, culminating in the development of highly sensitive, robust instruments that can reliably analyze biomolecules, particularly proteins and peptides; we identified 35 proteins from over 100 protein spots on a 2-D gel. Using this current technology, protein-expression profiling, which is actually a specialized form of mining, is an important principal application of proteomics. The information obtained has tremendous potential as a means of determining the pathogenesis, and detecting disease markers and potential targets for drug therapy in AD.
Similar content being viewed by others
References
Mattson, M. P., Gary, D. S., Chan, S. L., and Duan, W. 2001. Perturbed endoplasmic reticulum function, synaptic apoptosis and the pathogenesis of Alzheimer's disease. Biochem. Soc. Symp. 151-162.
Paschen, W. and Frandsen, A. 2001. Endoplasmic reticulum dysfunction-a common denominator for cell injury in acute and degenerative diseases of the brain? J. Neurochem. 79:719-725.
Tsuji, T., Shimohama, S., Kimura, J., and Shimizu, K. 1998. m-Calpain (calcium-activated neutral proteinase) in Alzheimer's disease brains. Neurosci. Lett. 248:109-112.
Lopez, M. F., Kristal, B. S., Chernokalskaya, E., Lazarev, A., Shestopalov, A. I., Bogdanova, A., and Robinson, M. 2000. High-throughput profiling of the mitochondrial proteome using affinity fractionation and automation. Electrophoresis 21:3427-3440.
Maimone, D., Dominici, R., and Grimaldi, L. M. 2001. Pharmacogenomics of neurodegenerative diseases. Eur. J. Pharmacol. 413:11-29.
Taylor, J. E., Tinklenberg, J. R., Eng, L. F., Yesavage, J. A., Vinogradov, S., Davies, H. G., Gonzalez DeWhitt, P. A., and Frossard, P. M. 1988. Association study between Alzheimer's disease and restriction fragment length polymorphisms at the human amyloid beta protein gene locus. Mol. Biol. Med. 5:167-172.
Fenn, J. B., Mann, M., Meng, C. K., Wong, S. F., and Whitehouse, C. M. 1989. Electrospray ionization for mass spectrometry of large biomolecules. Science 246:64-71.
Mullan, M. 1992. Familial Alzheimer's disease: Second gene locus located [editorial]. BMJ 305:1108-1109.
Kidd, P. M. 2000. Attention deficit/hyperactivity disorder (ADHD) in children: rationale for its integrative management. Altern. Med. Rev. 5:402-428.
Blum, D., Torch, S., Lambeng, N., Nissou, M., Benabid, A. L., Sadoul, R., and Verna, J. M. 2001. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog. Neurobiol. 65:135-172.
Blennow, K., Vanmechelen, E., and Hampel, H. 2001. CSF total tau, Abeta42 and phosphorylated tau protein as biomarkers for Alzheimer's disease. Mol. Neurobiol. 24:87-97.
Tilleman, K., Stevens, I., Spittaels, K., Haute, C. V., Clerens, S., Van Den Bergh, G., Geerts, H., Van Leuven, F., Vandesande, F., and Moens, L. 2002. Differential expression of brain proteins in glycogen synthase kinase-3 transgenic mice: a proteomics point of view. Proteomics 2:94-104.
Wilkins, M. R., Sanchez, J. C., Gooley, A. A., Appel, R. D., Humphery-Smith, I., Hochstrasser, D. F., and Williams, K. L. 1996. Progress with proteome projects: why all proteins expressed by a genome should be identified and how to do it. Biotechnol. Genet. Eng. Rev. 13:19-50.
Shevchenko, A., Wilm, M., Vorm, O., and Mann, M. 1996. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 68:850-858.
Mattila, K. M. and Frey, H. 1994. Alzheimer brain proteins investigated by two-dimensional gel electrophoresis with immobilized pH gradients in the first dimension [published erratum appears in Electrophoresis 1994 Jul; 15(7): following table of contents]. Electrophoresis 15:721-725.
Tsuji, T., Shimohama, S., Kamiya, S., Sazuka, T., and O'Hara, O. 1999. Analysis of brain proteins in Alzheimer's disease using high-resolution two-dimensional gel electrophoresis. J. Neurol. Sci. 166:100-106.
Edgar, P. F., Douglas, J. E., Knight, C., Cooper, G. J., Faull, R. L., and Kydd, R. 1999. Proteome map of the human hippocampus. Hippocampus 9:644-650.
Edgar, P. F., Schonberger, S. J., Dean, B., Faull, R. L., Kydd, R., and Cooper, G. J. 1999. A comparative proteome analysis of hippocampal tissue from schizophrenic and Alzheimer's disease individuals. Mol. Psychiatry 4:173-178.
Langen, H., Berndt, P., Roder, D., Cairns, N., Lubec, G., and Fountoulakis, M. 1999. Two-dimensional map of human brain proteins. Electrophoresis 20:907-916.
Schonberger, S. J., Edgar, P. F., Kydd, R., Faull, R. L., and Cooper, G. J. 2001. Proteomic analysis of the brain in Alzheimer's disease: Molecular phenotype of a complex disease process. Proteomics 1:1519-1528.
Gauss, C., Kalkum, M., Lowe, M., Lehrach, H., and Klose, J. 1999. Analysis of the mouse proteome. (I) Brain proteins: separation by two-dimensional electrophoresis and identification by mass spectrometry and genetic variation. Electrophoresis 20:575-600.
Rohlff, C. 2000. Proteomics in molecular medicine: applications in central nervous systems disorders. Electrophoresis 21:1227-1234.
Kilias, H., Gelfi, C., and Righetti, P. G. 1988. Isoenzyme analysis of lichen algae in immobilized pH gradients. Electrophoresis 9:187-191.
Adessi, C., Miege, C., Albrieux, C., and Rabilloud, T. 1997. Two-dimensional electrophoresis of membrane proteins: a current challenge for immobilized pH gradients. Electrophoresis 18:127-135.
Wilkins, M. R., Gasteiger, E., Sanchez, J. C., Bairoch, A., and Hochstrasser, D. F. 1998. Two-dimensional gel electrophoresis for proteome projects: the effects of protein hydrophobicity and copy number. Electrophoresis 19:1501-1505.
Anderson, N. L., Taylor, J., Scandora, A. E., Coulter, B. P., and Anderson, N. G. 1981. The TYCHO system for computer analysis of two-dimensional gel electrophoresis patterns. Clin. Chem. 27:1807-1820.
Rabilloud, T. 1996. Solubilization of proteins for electrophoretic analyses. Electrophoresis 17:813-829.
Henzel, W. J., Billeci, T. M., Stults, J. T., Wong, S. C., Grimley, C., and Watanabe, C. 1993. Identifying proteins from two-dimensional gels by molecular mass searching of peptide fragments in protein sequence databases. Proc. Natl. Acad. Sci. USA 90:5011-5015.
James, P., Quadroni, M., Carafoli, E., and Gonnet, G. 1993. Protein identification by mass profile fingerprinting. Biochem. Biophys. Res. Commun. 195:58-64.
Mann, M., Hojrup, P., and Roepstorff, P. 1993. Use of mass spectrometric molecular weight information to identify proteins in sequence databases. Biol. Mass Spectrom. 22:338-345.
Wilm, M., Shevchenko, A., Houthaeve, T., Breit, S., Schweigerer, L., Fotsis, T., and Mann, M. 1996. Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry. Nature 379:466-469.
Shevchenko, A., Wilm, M., and Mann, M. 1997. Peptide sequencing by mass spectrometry for homology searches and cloning of genes. J. Protein Chem. 16:481-490.
Rabilloud, T., Adessi, C., Giraudel, A., and Lunardi, J. 1997. Improvement of the solubilization of proteins in two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 18:307-316.
Roepstorff, P. 1997. Mass spectrometry in protein studies from genome to function. Curr. Opin. Biotechnol. 8:6-13.
Morris, H. R., Paxton, T., Dell, A., Langhorne, J., Berg, M., Bordoli, R. S., Hoyes, J., and Bateman, R. H. 1996. High sensitivity collisionally-activated decomposition tandem mass spectrometry on a novel quadrupole/orthogonal-acceleration time-of-flight mass spectrometer. Rapid Commun. Mass Spectrom. 10:889-896.
Morris, H. R., Paxton, T., Panico, M., McDowell, R., and Dell, A. 1997. A novel geometry mass spectrometer, the Q-TOF, for low-femtomole/attomole-range biopolymer sequencing. J. Prot. Chem. 16:469-479.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tsuji, T., Shiozaki, A., Kohno, R. et al. Proteomic Profiling and Neurodegeneration in Alzheimer's Disease. Neurochem Res 27, 1245–1253 (2002). https://doi.org/10.1023/A:1020941929414
Issue Date:
DOI: https://doi.org/10.1023/A:1020941929414